A Washington University/University of South Florida preclinical study finds that the novel nanoparticle delivers gene-level treatment to suppress KRAS-driven cancer without adverse effects

Scientists have found a rare, inherited gene mutation that raises the risk of pancreatic cancer and other malignancies

Findings could pave the way towards new  early detection or prevention tools

When combined with an existing test, new test detects nearly 70 percent of pancreatic cancers with a less than 5 percent false-positive rate